Patient Preferences for Treatment of Intermediate-Risk Prostate Cancer: A Discrete Choice Experiment - 04/05/26
, Jacob Whitman b
, Polly McCracken c
, Cailey J. Sanborn d
, Cameron A. Jones d
, Aniket Asees a
, Kathryn A. Marchetti e
, Benjamin J. Davies f
, Janel Hanmer c
, Bruce L. Jacobs f 
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
ABSTRACT |
Objective |
To evaluate patient preferences for intermediate-risk prostate cancer treatment and determine how these preferences vary across demographic groups using a discrete choice experiment.
Methods |
We recruited patients with intermediate-risk prostate cancer from a single-center urology clinic. In this survey, we included 8 attributes with 3-4 levels each to capture the full spectrum of prostate cancer treatment outcomes. We estimated patient preferences using a conditional logit model. We conducted a latent class analysis to identify patient subgroups with distinct choice behavior patterns. We used a multivariable linear probability model to assess the association between patient demographic characteristics and latent class membership.
Results |
A total of 88 patients completed the survey. In our primary analysis, patients had a significant preference towards avoiding bowel symptoms, erectile dysfunction, use of a catheter, or frequent trips to the facility. Bowel symptoms were considered the most important of all attributes, while urinary symptoms did not significantly influence patients’ choices. Patients placed a low weight on facing prolonged travel times or undergoing a major surgery. Latent class analysis revealed 2 groups based on survey response patterns: (1) patients averse to surgery and catheter and (2) patients averse to erectile and bowel symptoms. Older patients and racial and ethnic minorities were more likely to be members of the surgery and catheter-focused class.
Conclusion |
Overall, patients appear to prioritize avoiding bowel and sexual side effects after prostate cancer treatment. However, a subset of older patients may have strong preferences against surgery or the prolonged use of a catheter.
Le texte complet de cet article est disponible en PDF.Plan
| 1 | Presentations: Presented at the 26th Annual Meeting of the Society of Urologic Oncology (December 5th, 2025, Phoenix, AZ) and the 2026 American Urological Association Annual Meeting (May 18th, 2026, Washington, DC). |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
